Oxford genetics secures $2m for bioproduction optimisation R&D

By Dan Stanton contact

- Last updated on GMT

iStock/CaronB
iStock/CaronB

Related tags: Dna

Oxford Genetics hopes to provide improved bioinformatics in order to optimise mammalian bioproduction through a £1.6m grant.

The £1.61m ($2m) grant from Innovate UK was secured by Oxford genetics in order to undertake a research project exploring computational and synthetic biology approaches for optimising mammalian biomanufacturing processes.

“The production yields of many biological drugs are often very low, or at least unpredictable or variable,”​ CEO Ryan Cawood told Biopharma-Reporter.com. “For this reason by using statistical analysis to try and remove any uncertainty by designing proteins, viruses and cells better we can reduce these challenges.”

The funding will be spent primarily on internal research over a three year period, done in collaboration with the University of Oxford.

“The grant aims to deliver services to our biopharmaceutical clients by providing improved bioinformatics and software, coupled with a range of in house tools that we can help to deliver consistency and high productivity in the services we provide,”​ Cawood said. 

The news comes a month after Oxford Genetics secured a $1m grant​ – also from Innovate UK – to conduct research into increasing the efficiency and reducing the cost of scaling-up viral vector production.

Related news

Show more

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Related suppliers

Follow us

Products

View more

Webinars